WMWilliam Bruce MacLeod

William Bruce MacLeod

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


William Bruce MacLeod has a total of 549 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genomic analysis of Klebsiella pneumoniae causing community-acquired respiratory deaths among Zambian infants and children using targeted RNA-probe hybridization-capture metagenomics

    by Kenneth Lindstedt, Alyse Wheelock, Mulemba Samutela, Wasifa Kabir, Mwelwa Chasaya, Natasha Namuziya, Emilia Jumbe Marsden, Monica Kapasa, Chibamba Mumba, Bwalya Mulenga, et al.

    Klebsiella pneumoniae (Kp) is a leading cause of neonatal and infant deaths in sub-Saharan Africa and frequently associated with antimicrobial resistance. Previously, we identified Kp as a major cause of fatal community-associated lower respiratory infections among infants and children under five years in Lusaka, Zambia, using postmortem tissue sampling and pathogen specific multiplex qPCR. In this follow-up study, we employed a novel culture-independent RNA-probe hybridization-capture metagenomic sequencing approach, targeting Kp pan-genome core and accessory genes, to perform in-depth genomic analysis of Kp from eleven post-mortem lung biopsy samples from seven of these children. Analysis detected Kp in all cases except one, which identified Klebsiella quasipneumoniae subspecies similipneumoniae. Core-genome multi-locus sequence typing (cgMLST) revealed six clonal groups (CG607, CG1123, CG10072, CG280, CG3648, and CG10344) belonging to five sublineages (SL607, SL17, SL280, SL37, and SL10072), with perfect concordance between paired samples from the same case. Two infants sampled the same month harbored SL607 lineages sharing 621 out of 629 cgMLST alleles, suggesting clonal spread. Kp capsule (K) loci were detected in all but one case and included potential vaccine targets KL25, KL23, and KL122. Antimicrobial resistance genes were widespread among samples, particularly encoding resistance toward aminoglycosides, β-lactams, sulphonamides, tetracyclines, and trimethoprim. Extended spectrum β-lactamases were identified in four cases, three of which were blaCTX-M-15. The acquired Kp sideophore yersiniabactin (lineage ybt14) was identified in both cases associated with SL607, and the acquired siderophore aerobactin (lineage iuc5) was identified in one of these, suggesting possible convergence of antimicrobial resistance and hypervirulence. The detection of Kp with extensive antimicrobial resistance causing fatal community acquired pneumonia signals a deeply concerning epidemiologic shift from a largely nosocomial pathogen. This calls for urgent epidemiological investigations to better understand the burden, transmission dynamics, antimicrobial resistances, and potential vaccine targets for Kp in other community settings across sub-Saharan Africa.

  • Open Access

    Timing of ART Initiation With Treatment Policy Changes in South Africa: A Cohort Study

    by Dorina Onoya, Khumbo Mbbs Shumba, Caroline Msc Mudara, Cornelius Msc Nattey, Dickman Msc Gareta, Evelyn Bs Lauren, William Dsc Macleod, Matthew P. Dsc Fox, Koleka Mbbch Mlisana, Jacob Dsc Bor

    Background: Early antiretroviral therapy (ART) improves uptake, retention, and viral suppression. However, there is limited real-world data for high HIV burden settings, including South Africa. Methods: We conducted a retrospective cohort study using linked clinical CD4 and viral load (VL) data from South Africa's HIV treatment database (TIER.Net) and National Health Laboratory Service (NHLS). Our analysis included ART non-naive individuals entering HIV care between January 2010 and March 2017 in 4 provinces (KwaZulu-Natal, Northern Cape, Limpopo, and Mpumalanga). We estimated days from entry into HIV care (same day, 2–6 days, 7–89 days, and ≥90 days). Outcome measures included retention, viral suppression (VL <50 copies/mL), and CD4 recovery at 12 months. A Poisson regression model with adjusted Risk Ratios (aRR) was used to identify factors associated with rapid ART initiation (<7 days) at 5% significance level. Results: Among 1,211,966 individuals (median age 31 years, 69.6% female), 30% initiated ART on the day of diagnosis, 4.2% within 2–6 days, 26% within 7–89 days, and 39.8% after ≥90 days. Rapid ART initiation increased over time, with same-day initiations rising from 24.6% in 2010 to 60% in 2017. Factors associated with rapid ART initiation included female gender (aRR: 1.04; 95% CI: 1.03 to 1.04) and a lower CD4 count at entry. At 12 months, 77.6% of same-day initiators were retained, with 28.4% having a VL test and 61.2% achieving viral suppression. Conclusions: Rapid ART initiation has increased because of policy changes and healthcare worker efforts in South Africa, but addressing late entry into care and treatment nonadherence remains crucial.

  • Open Access

    Complexity of Adherence Challenges: Understanding Syndemic Factors Affecting HIV Treatment Adherence During Treatment Initiation in Cape Town, South Africa

    by Jeanette L. Kaiser, Erin Trowbridge, Taryn Vian, Jessica E. Haberer, Rashmi Paudel, Jillian DeMaria, Catherine Orrell, Lauren Jennings, Allen L. Gifford, Nafisa Halim, et al.

    People living with HIV and beginning antiretroviral therapy (ART) often struggle with medication adherence and attending appointments due to multi-level challenges such as depression symptoms, substance use, stigma and disclosure, food insecurity, health system challenges, transportation challenges, and gender inequity. The SUSTAIN trial seeks to improve initiation adherence through multiple monitoring and support interventions in three clinics in Mitchells Plain township, Cape Town, South Africa. We qualitatively explored the multi-level challenges impacting adherence at the individual, interpersonal, and structural levels among 60 study participants within the first six months after initiation on ART. The in-depth interview sample was selected purposively based on participant experiences with at least one of these factors reported through a baseline survey, gender, and age. We conducted a content analysis and utilized syndemic theory to understand the synergistic effects of multiple adherence challenges. To manage their HIV diagnosis, participants described positive and negative coping mechanisms, including how substance use affected adherence particularly on big event days (e.g., birthdays, holidays, or funerals). Participants described fears of stigma motivat decisions on disclosure of their HIV status and decreased potential social support, possibly reducing motivation to adhere to ART. Gender inequity reinforced experiences with and perceptions of stigma and disclosure. Participants indicated that food insecurity resulted in feelings of shame when associated with perceived larger appetites due to ART use and with lack of employment. Participants described both positive and negative ways the health system impacted their adherence and retention in care, citing information provided by clinic staff, clinician attitudes, and clinic operations. Misunderstandings regarding the strict timing of ART dose-taking (often from lack of clear information or counselling by clinicians) meant participants often had limited competence to make decisions about their dosing schedule and how to best integrate treatment into their daily lives. Participants described a notable fear of commuting to and from clinics due to dangerous and difficult paths on which muggings occurred frequently; women were at particular risk of violence. Often, participants mentioned multiple factors simultaneously affecting adherence, with additive or synergistic effects. Syndemic factors affecting ART adherence exist across multiple levels. Enhanced adherence counseling, designed as a behavior change intervention, might help PLWH cope with individual adherence barriers and support strategizing about ways to mitigate or overcome structural barriers. Continued efforts by government and implementers to address health system, gender inequity, and security challenges could further support ART adherence.


  • Open Access

    Ready for takeoff? exploring United States health care providers’ pretravel consultation priorities, gaps, barriers, and opportunities

    by Katherine A. Reifler, Swati S. Sharma, Nicholas A. Bergren, Elizabeth D. Barnett, Lin H. Chen, Jeffery A. Goad, William B. Macleod, Laura Kogelman, Davidson H. Hamer


  • Open Access

    Record linkage without patient identifiers: Proof of concept using data from South Africa’s national HIV program

    by Khumbo Shumba, Jacob Bor, Cornelius Nattey, Dickman Gareta, Evelyn Lauren, William Macleod, Matthew P. Fox, Adrian Puren, Koleka Mlisana, Dorina Onoya

    Linkage between health databases typically requires patient identifiers such as names and personal identification numbers. We developed and validated a record linkage strategy to combine administrative health databases without identifiers for South Africa’s public sector HIV program. We linked CD4 counts and HIV viral loads from South Africa’s TIER.Net with the National Health Laboratory Service (NHLS) database for patients receiving care between 2015–2019 in Ekurhuleni District (Gauteng Province). Linkage variables were result value, specimen collection date, facility of collection, year and month of birth, and sex. We used three matching strategies: exact matching on exact values of all variables, caliper matching allowing a ± 5 day window on result date, and specimen barcode matching using unique specimen identifiers. A sequential linkage approach applied specimen barcode, followed by exact, and then caliper matching. Exact and caliper matching were validated using barcodes (available for 34% of records in TIER.Net) as a “gold standard”. Performance measures were sensitivity, positive predictive value (PPV), share of patients linked, and percent increase in data points. We attempted to link 2,017,290 laboratory test results from TIER.Net (523,558 unique patients) with 2,414,059 NHLS test results. Exact matching achieved 69.0% sensitivity and 95.1% PPV. Caliper matching achieved 75% sensitivity and 94.5% PPV. Sequential linkage matched 41.9% using specimen barcodes, 51.3% through exact matching, and 6.8% through caliper matching, for 71.9% (95% CI: 71.9, 72.0) of test results matched overall, with 96.8% (95% CI: 96.7, 97.1) PPV and 85.9% (95% CI: 85.7, 85.9) sensitivity. This linked 86.0% (95% CI: 85.9, 86.1) of TIER.Net patients to the NHLS (N = 1,450,087), increasing laboratory results in TIER.Net by 62.6%. Linkage of TIER.Net and NHLS without patient identifiers attained high accuracy and yield without compromising privacy. The integrated cohort provides a more complete laboratory test history and supports more accurate HIV program indicator estimates.


  • Longitudinal Analysis of Nasopharyngeal Microbial Risk Markers for Fatal Acute Febrile Illness in a Zambian Birth Cohort

    by Aubrey R Odom, Jessica Anderson, Christopher J Gill, Rachel Pieciak, Arshad Ismail, William B MacLeod, W Evan Johnson, Rotem Lapidot

    Background: Fatal acute febrile illness (fAFI) is a known predecessor of many infant mortality events in low-resource settings, but early risk markers for this condition remain poorly understood. Nasopharyngeal (NP) microbiome patterns may influence the severity of these infections. Methods: We analyzed longitudinal changes in the NP microbiota of Zambian infants with fAFI onset compared to healthy controls, aiming to identify microbial indicators associated with severe illness outcomes. We conducted a pooled analysis of a longitudinal nested case-control study composed of 26 samples from 9 infants who developed fAFI compared with 69 samples from 10 healthy infants. Infants underwent nasopharyngeal sampling from 1 week through 14 weeks of age at 2–2.5-week intervals. We performed 16S rRNA gene amplicon sequencing on all infant NP samples and characterized NP microbiome maturation among infants with febrile acute febrile illness (fAFI+) and healthy controls (fAFI−). Results: Beta diversity measures of fAFI− infants were markedly higher than those of fAFI+ infants. The fAFI+ infant NP microbiome was marked by lower abundances of Dolosigranulum, Haemophilus, Streptococcus, and Corynebacterium, with higher relative presence of Pseudomonas. Conclusions: Our findings suggest that specific microbial community patterns and early NP microbiome dysbiosis may be associated with increased illness risk. These findings can motivate further studies to inform foundational markers for fAFI in infants, contributing to precision pediatric care.


  • Bordetella pertussis-related Respiratory Deaths in Infants From 4 Days to 6 Months of Age, Results From a 3-Year, Prospective Postmortem Surveillance Study in Lusaka, Zambia

    by William B. ScD MacLeod, Lawrence Mwananyanda, Geoffey Kwenda, Rachel Pieciak, Zachariah Bs Mupila, Caitriona Bs Murphy, Chilufya Bs Chikoti, Leah Forman, Flora Berklein, Rotem Md Lapidot, et al.

    Background: Since the 1990s, a remarkable decline in infant and child mortality has occurred. Continued progress in reducing mortality will need to focus on early infant and neonatal mortality and on less common diseases than pneumonia, diarrhea and malnutrition. One of the candidate diseases for focus is Bordetella pertussis, the principal cause of “whooping cough.” Methods: We conducted a study to measure the burden of deaths and calculate the population-attributable fraction of deaths due to B. pertussis. We collected postmortem nasopharyngeal swabs from subjects who died at the University Teaching Hospital or in the community and were brought to the University Teaching Hospital morgue 4 days to < 6 months of age. Infection with B. pertussis was determined with polymerase chain reaction testing. We assigned respiratory cause of death from the medical record or from a verbal autopsy collected from caregivers. Results: From August 2017 to August 2020, we collected nasopharyngeal samples from 2236 deceased subjects. Respiratory deaths were assigned to 29.0% of the deaths; 39.5% of community deaths were attributed to respiratory causes. Using 2 definitions of polymerase chain reaction positivity, the prevalence of B. pertussis in infant deaths was between 5.69 per 1000 deaths (95% confidence interval, 2.57–8.80) and 25.81 per 1000 deaths (95% confidence interval, 19.24–32.38). Pertussis accounted for between 0.22% and 0.81% of all infant deaths. Conclusions: In this population of infants, B. pertussis was a minor source of all-cause infant mortality. Our analysis does not support the need for further steps for population-level preventive strategies for the control of B. pertussis.


  • Open Access

    Aetiology of diarrhoea in children aged zero to nine years in low- and middle-income countries: A systematic review

    by Sinjini Das, Raghavee Neupane, Jennifer Beard, Hiwote Solomon, Monalisa Das, Neil Errickson, Jon L Simon, Yasir B Nisar, William B MacLeod, Davidson H Hamer

    Diarrhoeal diseases are among the leading causes of death in children aged <5 years in low- and middle-income countries (LMICs) [1]. Diarrhoea was estimated to account for 9% of deaths in children aged <5 years worldwide in 2013 (the most recent data available) [1]. There were about 444 000 deaths of children under 5 years of […]


  • Open Access

    The fall—And rise—In hospital-based care for people with HIV in South Africa: 2004–2017

    by Evelyn Lauren, Khumbo Shumba, Matthew P Fox, William MacLeod, Wendy Stevens, Koleka Mlisana, Jacob Bor, Dorina Onoya

    ART scale-up has reduced HIV mortality in South Africa. However, less is known about trends in hospital-based HIV care, which is costly and may indicate HIV-related morbidity. We assessed trends in hospital-based HIV care using the National Health Laboratory Service (NHLS) National HIV Cohort. Our study included all adults ≥18 years receiving care in South Africa’s public sector HIV program from 2004 to 2017 with at least one CD4 count/viral load test in the NHLS database. We compared trends in the number of patients presenting for and receiving HIV care by facility type: hospitals vs. primary care clinics. We then assessed trends and predictors of incident hospitalization, defined as 2 or more hospital-based lab tests taken within 7 days. Finally, we assessed whether trends in incident hospitalizations could be explained by changes in patient demographics, CD4 counts, or facility type at presentation. Data were analyzed on 9,624,951 patients. The percentage of patients presenting and receiving HIV care at hospitals (vs. clinics) declined over time, from approximately 60% in 2004 to 15% in 2017. Risk of hospitalization declined for patients entering care between 2004–2012 and modestly increased for patients entering care after 2012. The risk of hospitalization declined the most in age groups most affected by HIV. Over time, patients presented with higher CD4 counts and were more likely to present at clinics, and these changes explained almost half the decline in hospitalizations. The percentage of HIV care provided in hospitals declined as patients presented in better health and as treatment was increasingly managed at clinics. However, there may still be opportunities to reduce incident hospitalizations in people with HIV.


  • Open Access

    Characterization of longitudinal nasopharyngeal microbiome patterns in maternally HIV-exposed Zambian infants

    by Aubrey R. Odom, Christopher J. Gill, Rachel Pieciak, Arshad Ismail, Donald Thea, William B. MacLeod, W. Evan Johnson, Rotem Lapidot

    Background Previous studies of infants born to HIV-positive mothers have linked HIV exposure to poor outcomes from gastrointestinal and respiratory illnesses, and to overall increased mortality rates. The mechanism behind this is unknown, but it is possible that differences in the nasopharyngeal (NP) microbiome between infants who are HIV-unexposed or HIV-exposed could play a role in perpetuating some outcomes. Methods We conducted a longitudinal analysis of 170 NP swabs of healthy infants who are HIV-exposed (n=10) infants and their HIV(+) mothers, and infants who are HIV-unexposed, uninfected (HUU; n=10) .and their HIV(-) mothers. These swabs were identified from a sample library collected in Lusaka, Zambia between 2015 and 2016. Using 16S rRNA gene sequencing, we characterized the maturation of the microbiome over the first 14 weeks of life to determine what quantifiable differences exist between HIV-exposed and HUU infants, and what patterns are reflected in the mothers' NP microbiomes. Results In both HIV-exposed and HUU infants, Staphylococcus and Corynebacterium began as primary colonizers of the NP microbiome but were in time replaced by Dolosigranulum, Streptococcus, Moraxella and Haemophilus. When evaluating the interaction between HIV exposure status and time of sampling among infants, the microbe Staphylococcus haemolyticus showed a distinctive high association with HIV exposure at birth. When comparing infants to their mothers with paired analyses, HIV-exposed infants’ NP microbiome composition was only slightly different from their HIV(+) mothers at birth or 14 weeks, including in their carriage of S. pneumoniae, H. influenzae, and S. haemolyticus. Conclusions Our analyses indicate that the HIV-exposed infants in our study exhibit subtle differences in the NP microbial composition throughout the sampling interval. Given our results and the sampling limitations of our study, we believe that further research must be conducted in order to confidently understand the relationship between HIV exposure and infants’ NP microbiomes.